Overview

Vevo Therapeutics provides pharmaceutical companies with high-resolution data to accelerate drug discovery using its Mosaic platform and AI models. The platform works by pooling cells from many different patients into a single living organism and using single-cell RNA profiling to see how drugs affect gene expression across diverse populations in one experiment. Unlike competitors that test drugs on isolated cells in tubes, Vevo captures how drugs behave within living tissue to better predict real-world results. The company's goal is to make in vivo drug discovery scalable and precise to find better treatments for a wider range of patients.